ARTICLE

FindCenter AddIcon

Ketamine for Depression Still Too Expensive for Widespread Use

By Technology Networks — 2020

A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use. The study compared the costs and benefits of esketamine, an antidepressant approved by the U.S. Food and Drug Administration (FDA) last year for use in treatment-resistant major depressive disorder.

Read on www.technologynetworks.com

FindCenter Post-Image

Low Sense of Belonging Is a Predictor of Depression

A psychological sense of belonging is a greater predictor of major depression than other factors commonly associated with depression, such as social support, conflict and loneliness.

FindCenter AddIcon

EXPLORE TOPIC

Clinical Depression